Actinium-225 Conjugates of MAb CC49 and Humanized ΔCH2CC49-Reference-Cited by-同舟云学术

Actinium-225 Conjugates of MAb CC49 and Humanized ΔCH2CC49

Published:2002-04 Issue:2 Volume:17 Page:219-231
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Kennel Stephen J.¹,Brechbiel Martin W.²,Milenic Diane E.²,Schlom Jeffrey²,Mirzadeh Saed¹

Affiliation:

1. Life Sciences Division, Oak Ridge National Laboratory (ORNL), Oak Ridge, Tennessee

2. Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/108497802753773847

Reference28 articles.

1. Radioimmunotherapy with alpha-emitting nuclides

2. Radiotoxicity of Bismuth-213 Bound to Membranes of Monolayer and Spheroid Cultures of Tumor Cells

3. Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Normal Tissue Effects and Bone Marrow Relative Biological Effectiveness for an Actinium 225-Labeled HER2/neu-Targeting Antibody;International Journal of Radiation Oncology*Biology*Physics;2023-11

2. A review of recent advancements in Actinium‐225 labeled compounds and biomolecules for therapeutic purposes;Chemical Biology & Drug Design;2023-09-15

3. Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review;Pharmaceutics;2023-06-13

4. Physicochemical properties and antioxidant activities of marula fruit (Sclerocarya birrea subsp. Caffra) steamed and boiled before juice extraction;Food Science & Nutrition;2023-05-10

5. 225Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic;Pharmaceutics;2023-03-24